Gapping down
In reaction to earnings/guidance:
- DXC -24.3%, SDGR -19.4% (also FDA clearance IND application for SGR-2921), CARS -18.8%, WCC -18%, STAA -14%, OM -13.5%, SHC -12.7%, CCRN -12.5%, RVLV -10.3% (also authorizes new $100 mln share repurchase program), LNTH -10%, AMWL -9.9%, GT -9.1%, NGVT -9%, ETSY -9%, QCOM -8.8%, VAC -8.7%, COMM -8.1%, PYPL -8%, HUBS -7.3%, CGNX -7%, LMND -6.3%, ERII -6%, ACAD -6%, MGM -5.8%, HOOD -5.2%, CODI -5.1%, CLVT -4.7%, SHAK -4.7%, NFG -4.6%, PLNT -4.6%, CMI -4.6%, TS -4.5%, EPC -4.4%, AFG -4.3%, PBI -4.2%, NTR -4.1% (also announces strategic actions to reduce costs), FWRD -4%, ADPT -4%, TKR -3.8%, LAMR -3.5%, PCOR -3.3%, RGNX -3.2%, UFPI -3.2%, FNA -3%, JOBY -2.9%, PRVA -2.9%, GIL -2.8%, OXY -2.7%, AHH -2.7%, HCC -2.5%, PK -2.5%, RSI -2.4%, IRM -2.3%, ESMT -2.3%, PZZA -2.3%, WSC -2.2%, VC -2.2%, UGI -2.1%, PR -2.1%, MUSA -2%, KN -2%, ECPG -2%, MMS -2%, FORM -2%, HEP -2%, NE -1.9%, APG -1.9%, OHI -1.7%, COP -1.7%, EQIX -1.6%, ZG -1.6%, SNN -1.6%, GOOS -1.6%, HGV -1.6%, LNC -1.5%, OCSL -1.5%, MUR -1.4%, BV -1.4%, PBF -1.4%, SHOP -1.3%, VNT -1.3%, PWR -1.3%, NRDS -1.2%, SPG -1.2%, WMB -1.2%, FRT -1.2% (also increases dividend), BDX -1.2%, ET -1.1%, RYN -1.1%, BDC -1.1%, HST -1%, FMC -0.9%, BKH -0.9%, BCE -0.9%, MRO -0.7%
Other news:
- RBOT -39.4% (prices offering of 45.0 mln shares of common stock $1.00 per share)
- QS -13.6% (commences $300 mln stock offering)
- KRP -8% (to acquire mineral and royalty interests valued at $455 mln; prices offering of 7.25 mln common units at $14.00 per common unit)
- AMN -3.5% (in sympathy with CCRN earnings)
- NXPI -2.5% (CEO sold 20890 shares)
- RIVN -1.2% (former Waymo CEO John Krafcik named to board)
Analyst comments:
- DOCS -3.3% (downgraded to Neutral from Overweight at Piper Sandler)
- ROKU -1.9% (downgraded to Neutral from Buy at Citigroup)
- APLS -1.2% (downgraded to Neutral from Overweight at JP Morgan)